These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 26509852)

  • 1. Factors Affecting Short-term Mortality in Women With Ovarian, Tubal, or Primary Peritoneal Cancer: Population-Based Cohort Analysis of English National Cancer Registration Data.
    Barclay M; Gildea C; Poole J; Hirschowitz L; Menon U; Nordin A
    Int J Gynecol Cancer; 2016 Jan; 26(1):56-65. PubMed ID: 26509852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Restaging and Survival Analysis of 4036 Ovarian Cancer Patients According to the 2013 FIGO Classification for Ovarian, Fallopian Tube, and Primary Peritoneal Cancer.
    Rosendahl M; Høgdall CK; Mosgaard BJ
    Int J Gynecol Cancer; 2016 May; 26(4):680-7. PubMed ID: 26937751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and survival of epithelial ovarian, fallopian tube, peritoneal, and undesignated abdominal/pelvic cancers in Sweden 1960-2014: A population-based cohort study.
    Leandersson P; Hogberg T; Dickman PW; Malander S; Borgfeldt C
    BMC Cancer; 2021 Apr; 21(1):465. PubMed ID: 33902507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population-based study of survival for women with serous cancer of the ovary, fallopian tube, peritoneum or undesignated origin - on behalf of the Swedish gynecological cancer group (SweGCG).
    Dahm-Kähler P; Borgfeldt C; Holmberg E; Staf C; Falconer H; Bjurberg M; Kjölhede P; Rosenberg P; Stålberg K; Högberg T; Åvall-Lundqvist E
    Gynecol Oncol; 2017 Jan; 144(1):167-173. PubMed ID: 27817932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved short-term survival for advanced ovarian, tubal, and peritoneal cancer patients operated at teaching hospitals.
    Paulsen T; Kjaerheim K; Kaern J; Tretli S; Tropé C
    Int J Gynecol Cancer; 2006; 16 Suppl 1():11-7. PubMed ID: 16515561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring the added value of hospital-registry data for showing local service outcomes: cancers of the ovary, fallopian tube and peritoneum.
    Roder D; Davy M; Selva-Nayagam S; Paramasivam S; Adams J; Keefe D; Miller C; Powell K; Fusco K; Buranyi-Trevarton D; Oehler MK
    BMJ Open; 2019 Feb; 9(2):e024036. PubMed ID: 30782891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival differences in women with serous tubal, ovarian, peritoneal, and uterine carcinomas.
    Usach I; Blansit K; Chen LM; Ueda S; Brooks R; Kapp DS; Chan JK
    Am J Obstet Gynecol; 2015 Feb; 212(2):188.e1-6. PubMed ID: 25149685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Demographic clinical and prognostic characteristics of primary ovarian, peritoneal and tubal adenocarcinomas of serous histology--a prospective comparative study.
    Schnack TH; Sørensen RD; Nedergaard L; Høgdall C
    Gynecol Oncol; 2014 Nov; 135(2):278-84. PubMed ID: 25168689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics and management of diaphragm involvement in patients with primary advanced-stage ovarian, fallopian tube, or peritoneal cancer.
    Einenkel J; Ott R; Handzel R; Braumann UD; Horn LC
    Int J Gynecol Cancer; 2009 Oct; 19(7):1288-97. PubMed ID: 19823067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Weekly topotecan for recurrent ovarian, fallopian tube and primary peritoneal carcinoma: tolerability and efficacy study--the Israeli experience.
    Safra T; Berman T; Yachnin A; Bruchim I; Meirovitz M; Barak F; Atlas I; Levy T; Rosengarten OS
    Int J Gynecol Cancer; 2013 Mar; 23(3):475-80. PubMed ID: 23435437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathologic characteristics and survival in BRCA1- and BRCA2-related adnexal cancer: are they different?
    Reitsma W; de Bock GH; Oosterwijk JC; ten Hoor KA; Hollema H; Mourits MJ
    Int J Gynecol Cancer; 2012 May; 22(4):579-85. PubMed ID: 22274543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer of the ovary, fallopian tube, and peritoneum.
    Berek JS; Crum C; Friedlander M
    Int J Gynaecol Obstet; 2015 Oct; 131 Suppl 2():S111-22. PubMed ID: 26433667
    [No Abstract]   [Full Text] [Related]  

  • 13. Maximal cytoreduction in patients with FIGO stage IIIC to stage IV ovarian, fallopian, and peritoneal cancer in day-to-day practice: a Retrospective French Multicentric Study.
    Luyckx M; Leblanc E; Filleron T; Morice P; Darai E; Classe JM; Ferron G; Stoeckle E; Pomel C; Vinet B; Chereau E; Bergzoll C; Querleu D
    Int J Gynecol Cancer; 2012 Oct; 22(8):1337-43. PubMed ID: 22964527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Outcomes among Women with Mucinous Adenocarcinoma of the Ovary.
    Massad LS; Gao F; Hagemann I; Powell M
    Gynecol Obstet Invest; 2016; 81(5):411-5. PubMed ID: 26583769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of published models and prognostic variables in epithelial ovarian cancer at Mayo Clinic.
    Wahner Hendrickson AE; Hawthorne KM; Goode EL; Kalli KR; Goergen KM; Bakkum-Gamez JN; Cliby WA; Keeney GL; Visscher DW; Tarabishy Y; Oberg AL; Hartmann LC; Maurer MJ
    Gynecol Oncol; 2015 Apr; 137(1):77-85. PubMed ID: 25620544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in ovarian, fallopian tube, and primary peritoneal cancer incidence, mortality, and survival: A 15-year population-based analysis.
    Somasegar S; Reddy RA; Chow S; Dorigo O; Renz M; Karam A
    Gynecol Oncol; 2024 May; 184():190-197. PubMed ID: 38330833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. International Federation of gynecology and obstetrics staging classification for cancer of the ovary, fallopian tube, and peritoneum: estimation of survival in patients with node-positive epithelial ovarian cancer.
    Pereira A; Pérez-Medina T; Magrina JF; Magtibay PM; Rodríguez-Tapia A; Peregrin I; Mendizabal E; Ortiz-Quintana L
    Int J Gynecol Cancer; 2015 Jan; 25(1):49-54. PubMed ID: 25405578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The significance of the pattern of serum CA125 level ascent to above the normal range in epithelial ovarian, primary peritoneal and tubal carcinoma patients.
    Levy T; Weiser R; Boaz M; Ben Shem E; Golan A; Menczer J
    Gynecol Oncol; 2013 Apr; 129(1):165-8. PubMed ID: 23274778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in the incidence of serous fallopian tube, ovarian, and peritoneal cancer in the US.
    Liao CI; Chow S; Chen LM; Kapp DS; Mann A; Chan JK
    Gynecol Oncol; 2018 May; 149(2):318-323. PubMed ID: 29514737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic role of early versus late onset of bone metastasis in patients with carcinoma of the ovary, peritoneum and fallopian tube.
    Sehouli J; Olschewski J; Schotters V; Fotopoulou C; Pietzner K
    Ann Oncol; 2013 Dec; 24(12):3024-8. PubMed ID: 24130264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.